M. Witzens-Harig

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma

W. Klapper, C. Buske, M. Dreyling, 2015, Leukemia.

Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment

A. Ho, K. Lisenko, M. Cremer, 2016, Leukemia & lymphoma.

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis

W. Klapper, A. Stroux, M. Herold, 2020, Annals of Hematology.

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

A. Ho, K. Lisenko, T. Dittrich, 2016, BMC Cancer.

[Mild bleeding diathesis in a 62-year-old woman with hereditary thrombocytopenia].

U. Felbor, M. Hundemer, B. Lehmann, 2013, Der Internist.